It is a series of medical decisions based on the patients progress, tolerance, risks, goals, and health markers
By helping patients find answers to their questions about cost and coverage, you can make the best possible decisions regarding their treatment for the disease of obesity
Daily Injectable Formulations: Liraglutide (Victoza) for diabetes starts at 0.6 mg daily for one week, then increases to 1.2 mg daily, with a possible increase to 1.8 mg if needed
Cell (2015) 161:26476
Left untreated, diabetes and obesity pose grave health risks 5 Some common risks of untreated diabetes and obesity include high blood pressure, cardiovascular disease, coronary artery disease, cancer, stroke, increased risk of mental illness, back and joint pain, and difficulty with daily functioning
This triple-action mechanism also leads to a potentially greater reduction in average weight loss compared to older medications, making it one of the most promising drugs on the horizon for weight management